Animal Models for Study of Pathophysiological Mechanisms of Hypertension and Its Complications

Essential hypertension is still an important health care problem. It is necessary to investigate its mechanisms in animal models. The potential clinical importance of such experimental research might be expected. This Special Issue concerned several important topics. First, several studies focused o...

Full description

Saved in:
Bibliographic Details
Other Authors: Zicha, Josef (Editor), Vaněčková, Ivana (Editor)
Format: Electronic Book Chapter
Language:English
Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
Subjects:
SHR
age
Online Access:DOAB: download the publication
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000naaaa2200000uu 4500
001 doab_20_500_12854_96766
005 20230202
003 oapen
006 m o d
007 cr|mn|---annan
008 20230202s2023 xx |||||o ||| 0|eng d
020 |a books978-3-0365-6319-0 
020 |a 9783036563183 
020 |a 9783036563190 
040 |a oapen  |c oapen 
024 7 |a 10.3390/books978-3-0365-6319-0  |c doi 
041 0 |a eng 
042 |a dc 
072 7 |a M  |2 bicssc 
072 7 |a MJD  |2 bicssc 
100 1 |a Zicha, Josef  |4 edt 
700 1 |a Vaněčková, Ivana  |4 edt 
700 1 |a Zicha, Josef  |4 oth 
700 1 |a Vaněčková, Ivana  |4 oth 
245 1 0 |a Animal Models for Study of Pathophysiological Mechanisms of Hypertension and Its Complications 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2023 
300 |a 1 electronic resource (296 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Essential hypertension is still an important health care problem. It is necessary to investigate its mechanisms in animal models. The potential clinical importance of such experimental research might be expected. This Special Issue concerned several important topics. First, several studies focused on the pathophysiological mechanisms responsible for blood pressure elevation during hypertension development, organ damage in chronic hypertension, and drugs targeting hypertension and/or its complications. Other studies were interested in the participation of central and peripheral blood pressure control, changes in vascular structure and function, and neural, humoral, and endocrine factors. Furthermore, the contribution of altered redox signaling, chronic inflammation, microbiome changes, and interactions of genetic and environmental factors were evaluated in multiple papers. Finally, special attention was paid to the progress in pharmacological tools for the control of hypertension and associated organ damage, genetic modifications to alter blood pressure levels, and non-pharmacological interventions attenuating hypertension or its complications. The original articles or reviews covered the interesting aspects of the pathophysiology of hypertension and associated end-organ damage, the use of various experimental hypertensive models, and the importance of specific environmental factors acting in distinct phases of the ontogeny. We especially appreciate the presentation of new ideas and the critical discussion of traditional theories. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
650 7 |a Medicine  |2 bicssc 
650 7 |a Cardiovascular medicine  |2 bicssc 
653 |a developmental origins of health and disease (DOHaD) 
653 |a gut microbiota 
653 |a hypertension 
653 |a short chain fatty acid 
653 |a oxidative stress 
653 |a probiotics 
653 |a prebiotics 
653 |a renin-angiotensin system 
653 |a fibroblast growth factor-23 
653 |a left ventricular hypertrophy 
653 |a renin-angiotensin-aldosterone system 
653 |a losartan 
653 |a canrenone 
653 |a Hyp mice 
653 |a X-linked hypophosphatemia 
653 |a hairless SHRM 
653 |a cold acclimation 
653 |a cardiac Cx43 
653 |a extracellular matrix 
653 |a thyroid hormones 
653 |a SHR 
653 |a sacubitril/valsartan 
653 |a ARNI 
653 |a ivabradine 
653 |a remodelling 
653 |a cardiac dysfunction 
653 |a fibrosis 
653 |a angiotensin II 
653 |a angiotensin 1-7 
653 |a knock-out 
653 |a genome-editing 
653 |a SHRSP 
653 |a Dahl SS 
653 |a foetal programming of hypertension 
653 |a sympathetic neurotransmission 
653 |a sympathetic innervation 
653 |a vascular remodelling 
653 |a foetal undernutrition 
653 |a old SHR 
653 |a antihypertensive therapy 
653 |a blood pressure monitoring 
653 |a LV hypertrophy 
653 |a ECM markers 
653 |a cardiac fibrosis 
653 |a SHR-CRP 
653 |a SGLT-2 inhibitor 
653 |a gene expression 
653 |a age 
653 |a lipid metabolism 
653 |a nitric oxide 
653 |a l-NAME 
653 |a rostral ventrolateral medulla 
653 |a aging 
653 |a reactive oxygen species 
653 |a NADPH oxidase activator 1 
653 |a mitochondria 
653 |a chloride 
653 |a calcium-activated chloride channel 
653 |a Na+-K+-2Cl− cotransporter 1 
653 |a TMEM16A 
653 |a smooth muscle 
653 |a fetal undernutrition programming 
653 |a cross-fostering 
653 |a lactation period 
653 |a cardiovascular hypertrophy 
653 |a adipose tissue browning 
653 |a cardiovascular disease 
653 |a catecholamines 
653 |a liquid chromatography-tandem mass spectrometry 
653 |a SGLT-2 inhibition 
653 |a proteinuria 
653 |a uninephrectomized salt-loaded 
653 |a two-kidney 
653 |a one-clip hypertension 
653 |a fawn-hooded hypertensive rat 
653 |a ApoE KO 
653 |a apolipoprotein E knockout mice 
653 |a atherosclerosis 
653 |a Na,K-ATPase 
653 |a TCTP 
653 |a TCTP-overexpressing transgenic mice 
653 |a translationally controlled tumor protein 
653 |a TCTP-TG 
653 |a experimental hypertension 
653 |a bone 
653 |a rats 
653 |a taurine 
653 |a magnesium 
653 |a 24 h urine(24U) 
653 |a stroke-prone spontaneously hypertensive rat 
653 |a young SHR 
653 |a combination therapy 
653 |a treatment effect 
653 |a systolic blood pressure 
856 4 0 |a www.oapen.org  |u https://mdpi.com/books/pdfview/book/6712  |7 0  |z DOAB: download the publication 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/96766  |7 0  |z DOAB: description of the publication